Table 3.
Provider-reported vaccination status: Multivariable associations with scale and factor score means (n = 7,173).
| Vaccinated n (%) |
Scale (8 items) | Benefits (4 items) | Factors Harms (2 items) | Trust (2 items) | |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||
| Mean (SE) | OR (95% CI) | Mean (SE) | OR (95% CI) | Mean (SE) | OR (95% CI) | Mean (SE) | OR (95% CI) | ||
| Tdap | |||||||||
| Yes | 5,969 (83%) | 8.30 (0.03) | 1.20 (1.11, 1.30) | 8.63 (0.04) | 1.20 (1.12, 1.28) | 3.19 (0.06) | -- | 9.16 (0.03) | -- |
| No | 1,204 (17%) | 7.92 (0.08) | Reference | 8.13 (0.10) | Reference | 3.53 (0.13) | 8.97 (0.06) | ||
| Meningococcal | |||||||||
| Yes | 4,766 (66%) | 8.41 (0.04) | 1.31 (1.22, 1.39) | 8.72 (0.04) | 1.17 (1.09, 1.26) | 3.05 (0.07) | 0.96 (0.92, 1.00) | 9.24 (0.04) | 1.09 (1.01, 1.18) |
| No | 2,407 (34%) | 7.89 (0.05) | Reference | 8.17 (0.07) | Reference | 3.65 (0.09) | Reference | 8.89 (0.05) | Reference |
| HPV (≥1 dose)a | |||||||||
| Yes | 1,778 (52%) | 8.57 (0.05) | 1.52 (1.38, 1.68) | 8.94 (0.05) | 1.36 (1.24, 1.49) | 2.95 (0.10) | 0.93 (0.88, 0.99) | 9.34 (0.04) | -- |
| No | 1,641 (48%) | 7.87 (0.06) | Reference | 8.16 (0.08) | Reference | 3.79 (0.10) | Reference | 8.96 (0.07) | |
| HPV (3 doses)a | |||||||||
| Yes | 1,253 (37%) | 8.61 (0.06) | 1.46 (1.31, 1.64) | 9.01 (0.06) | 1.41 (1.28, 1.55) | 2.93 (0.12) | -- | 9.38 (0.05) | -- |
| No | 2,166 (63%) | 8.01 (0.05) | Reference | 8.30 (0.07) | Reference | 3.60 (0.09) | 9.03 (0.06) | ||
Note: CI: confidence interval. HPV: human papillomavirus. OR: odds ratio. SE: standard error. Tdap: tetanus, diphtheria, and acellular pertussis. Table shows raw frequencies and weighted estimates. Models controlled for child’s race/ethnicity, mother’s educational attainment, and annual household income. Dashes (--) indicate that multivariable findings are not presented because bivariate analyses did not yield statistically significant associations.
a
Human papillomavirus vaccination coverage assessed only for females (n=3,419).